Benjamin J. Hindson - 23 May 2023 Form 4 Insider Report for 10x Genomics, Inc. (TXG)

Role: President and Chief Scientific Officer, Director
Signature: /s/ Eric S. Whitaker, as Attorney-in-Fact for Benjamin J. Hindson
Issuer symbol: TXG
Transactions as of: 23 May 2023
Net transactions value: -$131,487
Form type: 4
Filing time: 25 May 2023, 17:49:27 UTC
Previous filing: 23 Mar 2023
Next filing: 21 Jul 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TXG	Class A Common Stock	Sale	$13,379	-243	-0.08%	$55.06	286,381	23 May 2023	Direct	F1
transaction	TXG	Class A Common Stock	Sale	$34,082	-619	-0.22%	$55.06	285,762	23 May 2023	Direct	F1
transaction	TXG	Class A Common Stock	Sale	$40,471	-735	-0.26%	$55.06	285,027	23 May 2023	Direct	F1
transaction	TXG	Class A Common Stock	Sale	$43,553	-791	-0.28%	$55.06	284,236	23 May 2023	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.

Remarks:

President and Chief Scientific Officer